SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided...
Hence then, the article about ideaya biosciences upcoming investor relations events and updated darovasertib topline results guidance from phase 2 3 optimum 02 trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial )
Also on site :
- Walmart on Dewey Avenue in Greece closed to the public Thursday afternoon
- Carlos Puyol, David Villa & more in attendance for Spain vs Austria 2026 FIFA World Cup clash
- Vinyl Collectors Will Love Amazon’s ‘Attractive’ Retro 9-Tier Record Player Stand